Daily TIP

The Daily TIP: Netanyahu: "Close Cooperation" Led to Release of Israeli Embassy Staff from Jordan

Posted by Tip Staff - July 24, 2017

Netanyahu: "Close Cooperation" Led to Release of Israeli Embassy Staff from Jordan
Palestinian Who Slaughtered Israeli Family to Receive $3,120/Month Reward From PA
Netanyahu Welcomes Georgian PM, Celebrating 25 Years of Diplomatic Ties
In Record Pharma Buyout Israeli Drug Maker to Be Purchased by Japanese Firm for $1.1 Billion


Netanyahu: "Close Cooperation" Led to Release of Israeli Embassy Staff from Jordan

The release of Israel's Amman embassy staff in Jordan and their return to Israel was made possible by "close cooperation" between Israeli and Jordanian authorities, Israeli Prime Minister Benjamin Netanyahu said, The Times of Israel reported Monday.

A worker had stabbed an Israeli security guard who worked at the embassy Sunday, stabbing him with a screwdriver. In self-defense the guard shot and killed the assailant. A second man, the landlord of the guard's apartment was wounded in the incident and later died.

The Jordanian government demanded an interrogation of the guard by police and surrounded the embassy, not allowing the staff to leave. Haaretz reported that a deal was worked out between the two governments had Jordanian police hear a description of the incident by the guard in front of the embassy staff.

Earlier in the day a former Israeli senior national security official said that it's in the "basic interest" of both Israel and Jordan to resolve a diplomatic crisis stemming from Sunday’s terrorist attack at the Israeli Embassy compound.

Dr. Eran Lerman, a former member of National Security Council and currently a senior research associate at the Begin-Sadat Center for Strategic Studies, said that for Israel "there's no alternative to the relationship with Jordan." He explained that Jordan is an important partner for Israel, both in regards to countering the current unrest at the Temple Mount in Jerusalem---which is being fanned by Palestinian incitement---as well as threats emanating from Syria, which borders both nations.



Palestinian Who Slaughtered Israeli Family to Receive $3,120/Month Reward From PA

The family of Omar al-Abed, the knife-wielding Palestinian terrorist who brutally murdered three members of the Salomon family at Shabbat dinner on Friday, will enjoy a generous payment from the Palestinian Authority (PA) for the killing of Jews.

As a result of the PA's program to pay Palestinians who commit terror attacks---sometimes termed the "Pay-for-Slay-Program"---the al-Abed family is expected to receive a monthly lifetime salary of $3,120, Liel Leibovitz reported Sunday for Tablet Magazine. This sum is typically given to terrorists sentenced to 30 years or more in prison.

Leibovitz's assessment follows reports that the PA increased its spending on salaries to terrorists and their families in 2017. Palestinian Media Watch (PMW) reported Wednesday that payments to jailed terrorists increased 13%, from 488 million shekels ($135 million) in 2016 to 550 million shekels ($158 million) this year. The overall 2017 budget for payments to terrorists and their families amounts to 1.237 billion shekels ($355 million).

This revelation comes as Israel deals with rising tension over the placement of metal detectors on Temple Mount following a July 14 terrorist attack there that killed two Israeli police officers.

The crisis at the Temple Mount---the holiest site in Judaism and one of the holiest in Islam---has been fueled by incitement from Palestinian leaders, who have strongly objected to the installation of metal detectors at the complex.



Netanyahu Welcomes Georgian PM, Celebrating 25 Years of Diplomatic Ties

Israeli Prime Minister Benjamin Netanyahu welcomed his Georgian counterpart, Giorgi Kvirikashvili to Jerusalem Monday, saying, "we are kindred souls living in a very difficult part of the world so we are small countries that show a big future."

2017 marks 25 years of diplomatic ties between the two nations though Netanyahu remarked that there "are 2600 years that connect our people through the span of Jewish history in Georgia." He also acknowledged the presence of 100,000 citizens of Georgian-Jewish extraction living in Israel.

"During the last several years, we have seen significant progress in our bilateral relations," Kvirkashvili said. "We have achievements practically in all spheres: in agriculture, in high technologies, in security and as you mentioned, the threats that our nations face are quite similar."

July has been a busy month for high-level Israeli diplomacy.

Last week Netanyahu was in Budapest to meet with the leaders of the Visegrad Group—Hungary, Poland, Czech Republic and Slovakia— and all five agreed to work toward improving European Union ties with Israel in the economic, political, strategic, regional, and technological spheres.

At the beginning of the month Indian Prime Minister Narendra Modi made a historic three day visit to Israel, strengthening ties between his nation and Israel.

Modi's successful visit to Israel prompted historian Walter Russell Mead to observe at The American Interest, "From the Gulf to Africa to all across Asia, Israeli diplomacy is more active and diversified than ever before."



In Record Pharma Buyout Israeli Drug Maker to Be Purchased by Japanese Firm for $1.1 Billion

NeuroDerm, an Israeli clinical-stage pharmaceutical company developing next-generation treatments for central nervous system disorders, will be acquired for $1.1 billion in cash by Japanese company Mitsubishi Tanabe Pharma Corporation.

The deal, expected to close in late 2017 pending shareholder approval, reportedly would be the largest-ever acquisition of an Israeli pharmaceuticals company. The transaction will be completed by way of a merger under the Israeli Companies Law.

NeuroDerm’s drug-device combinations enable new routes of administration for existing drugs that overcome their current deficiencies and achieve enhanced clinical efficacy.

Its portfolio of four product candidates specifically addresses major unmet needs in the field of Parkinson’s disease and cognition, from the moderate to the most severe stage of the disease.

“We believe that this transaction will yield important benefits for NeuroDerm’s shareholders and the Parkinson’s disease patients that urgently need new therapies,” said NeuroDerm CEO Dr. Oded Lieberman.

Mitsubishi Tanabe is banking on Neuroderm’s Parkinson’s drug, now in advanced clinical trials in the United States and Europe, to help it reach a US sales target of $722 million by 2020.

The deal will be the largest acquisition of an Israeli company by a Japanese company since Rakuten’s $900 million purchase of chat app Viber in 2014.

NeuroDerm, based in Rehovot, expects to launch two Parkinson’s products in the next two years.

(via Israel21c)


Be the first to comment

Please check your e-mail for a link to activate your account.